Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 14, 2023 16:05 ET | Source: Codexis, Inc.

Codexis to Participate in 35th Annual Piper Sandler Healthcare Conference

REDWOOD CITY, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the 35th Annual Piper Sandler...
November 02, 2023 16:05 ET | Source: Codexis, Inc.

Codexis Reports Third Quarter 2023 Financial Results

Company Remains on Track to Demonstrate Gram-Scale Synthesis with ECO Synthesis™ Platform for RNAi Therapeutics Production by End of Year Strong Financial Position Enables Projected Runway to...
October 31, 2023 16:05 ET | Source: Codexis, Inc.

Codexis to Participate in Upcoming Healthcare Conferences

REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that management will participate in four upcoming investor...
October 27, 2023 15:35 ET | Source: Codexis, Inc.

Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe

REDWOOD CITY, Calif., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced a presentation highlighting the role of an enzymatic...
October 26, 2023 16:05 ET | Source: Codexis, Inc.

Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe

REDWOOD CITY, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced a presentation highlighting the role of an enzymatic...
October 19, 2023 16:05 ET | Source: Codexis, Inc.

Codexis to Report Third Quarter 2023 Financial Results on November 2

REDWOOD CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the third...
September 29, 2023 07:05 ET | Source: Codexis, Inc.

Codexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton Award

REDWOOD CITY, Calif., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced President and Chief Executive Officer Stephen Dilly,...
September 18, 2023 16:05 ET | Source: Codexis, Inc.

Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award

REDWOOD CITY, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced Stephen Dilly, MBBS, PhD, President and Chief Executive...
September 12, 2023 16:05 ET | Source: Codexis, Inc.

Codexis to Participate in Cantor Global Healthcare Conference

REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Cantor Global Healthcare...
September 07, 2023 16:05 ET | Source: Codexis, Inc.

Codexis Announces Agreement for Assignment and Assumption of San Carlos Facility Lease

REDWOOD CITY, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company has executed an Assignment and Assumption of...